This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Jan;146(1):145.

doi: 10.1016/j.jpeds.2004.10.032.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial

Richard M Glass¹

Affiliations

PMID: 15644846
DOI: 10.1016/j.jpeds.2004.10.032

Comment

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial

Richard M Glass. J Pediatr. 2005 Jan.

. 2005 Jan;146(1):145.

doi: 10.1016/j.jpeds.2004.10.032.

Author

Richard M Glass¹

Affiliation

¹ University of Chicago, Chicago, IL 60637, USA.

PMID: 15644846
DOI: 10.1016/j.jpeds.2004.10.032

No abstract available

PubMed Disclaimer

Comment on

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team. March J, et al. JAMA. 2004 Aug 18;292(7):807-20. doi: 10.1001/jama.292.7.807. JAMA. 2004. PMID: 15315995 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.